Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,893 | -8,591 | -11,631 | -1,140 | -420 |
| Depreciation Amortization | 1 | 1 | 353 | 103 | 1 |
| Other Working Capital | 637 | 208 | -849 | 336 | -8 |
| Other Operating Activity | 2,622 | 2,044 | 9,629 | 205 | 154 |
| Operating Cash Flow | $-7,633 | $-6,339 | $-2,498 | $-495 | $-274 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -350 | 0 | 0 | 35 | 0 |
| Investing Cash Flow | $-350 | $N/A | $N/A | $35 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | -335 | 350 | 200 |
| Common Stock Issued | 5,607 | 9,247 | 6,424 | 40 | N/A |
| Other Financing Activity | 0 | 0 | 260 | 0 | 0 |
| Financing Cash Flow | $5,607 | $9,247 | $6,349 | $390 | $200 |
| Beginning Cash Position | 6,777 | 3,869 | 18 | 88 | 162 |
| End Cash Position | 4,401 | 6,777 | 3,869 | 18 | 88 |
| Net Cash Flow | $-2,376 | $2,908 | $3,851 | $-70 | $-74 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,633 | -6,339 | -2,498 | -495 | -274 |
| Free Cash Flow | -7,633 | -6,339 | -2,498 | -495 | -274 |